TCL Archive In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research May 17, 1991
TCL Archive DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology October 10, 1980
TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
